Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Octave Bioscience, Inc.

Octave Bioscience Expands Medical Leadership to Accelerate Precision Care in Neurodegenerative Disease
From Octave Bioscience, Inc.
Via Business Wire
Octave MSDA Test Gains NY State Certification, Expanding Access Nationwide
From Octave Bioscience, Inc.
Via Business Wire
Octave Bioscience’s MSDA Test Proven to Provide Clinically Actionable Insights That Drive Meaningful Clinical Decisions in MS Care
From Octave Bioscience, Inc.
Via Business Wire
Octave® Bioscience Continues Commercial Momentum with Addition of Accomplished CFO Marcel Konrad
From Octave Bioscience, Inc.
Via Business Wire
Octave® Bioscience, Inc. Announces Publication in Nature Communications
From Octave Bioscience, Inc.
Via Business Wire
Octave Bioscience Accelerates Leadership in Precision Care for Neurodegenerative Diseases with Addition of World-Class Commercial Executives
From Octave Bioscience, Inc.
Via Business Wire
Octave® Bioscience, Inc. Announces Chairman of the Board, CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for its Precision Care Solution
From Octave Bioscience, Inc.
Via Business Wire
Octave® Bioscience, Inc. Receives $10 Million Grant from The Michael J. Fox Foundation to Develop and Validate Multi-Analyte Protein Biomarker Test for Parkinson’s Disease Assessments
From Octave Bioscience, Inc.
Via Business Wire
Octave® Bioscience, Inc. Presents Data Highlighting Application and Impact of its Precision Care Solution at MSMilan2023
From Octave Bioscience, Inc.
Via Business Wire
Octave® Bioscience, Inc. Announces Real-World Study Using its Multimodal Precision Care Solution for Multiple Sclerosis Patient Management
From Octave Bioscience, Inc.
Via Business Wire
Octave® Bioscience, Inc. Announces Publication of Clinical Validation Study Results of its Novel, Multivariate Multiple Sclerosis Disease Activity (MSDA) Blood Test
From Octave Bioscience, Inc.
Via Business Wire
Octave® Bioscience, Inc.’s Solution for Transforming the Care Paradigm in MS has been Selected as a Finalist in Fast Company’s 2023 Innovation by Design Awards
From Octave Bioscience, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.